Phosphorus oxychloride → HCID 86036625, compound
Reaction equation
[N:1]1[CH:6]=[CH:5][CH:4]=[CH:3][C:2]=1[C:7]1[CH:8]=[C:9]2[C:14](=[CH:15][CH:16]=1)[N:13]=[CH:12][N:11]=[C:10]2O.P(Cl)(Cl)([Cl:20])=O>>[Cl:20][C:10]1[C:9]2[C:14](=[CH:15][CH:16]=[C:7]([C:2]3[CH:3]=[CH:4][CH:5]=[CH:6][N:1]=3)[CH:8]=2)[N:13]=[CH:12][N:11]=1Participants
Procedure
Preparation D12, Step 3: A suspension of 6-(pyridin-2-yl)quinazolin-4-ol (106 mg, 0.47 mmol) in phosphorous oxychloride (15 mL) was heated at reflux for 1.5 h, during which time a clear, amber solution was observed. The solution was cooled to room temperature, concentrated in-vacuo, and stripped 2× from 30 mL methylene chloride to remove any remaining phosphorous oxychloride. The residue was partitioned between EtOAc and saturated sodium bicarbonate, and the mixture was stirred for 10 min. The layers were separated, and the organic phase was washed successively with saturated sodium bicarbonate, water, and brine, dried over sodium sulfate, then concentrated in-vacuo. The residue was purified over silica gel, eluting with methylene chloride followed by 1:1 methylene chloride/EtOAc, to yield 105 mg of 4-chloro-6-(pyridin-2-yl)quinazoline as a white solid. MS (ES+)=242 (M+H+).
Workup
- customPreparation D12, Step 3
- temperaturewas heated
- temperatureat reflux for 1.5 h, during which time a clear, amber solution
- concentrationconcentrated in-vacuo
- customto remove any remaining phosphorous oxychloride
- customThe residue was partitioned between EtOAc and saturated sodium bicarbonate
- customThe layers were separated
- washthe organic phase was washed successively with saturated sodium bicarbonate, water, and brine
- dry with materialdried over sodium sulfate
- concentrationconcentrated in-vacuo
- customThe residue was purified over silica gel
- washeluting with methylene chloride
Sources & evidence
- ORD record
- ord-a72bcd36637f4af59b4e83121a54f721
- Source dataset
- uspto-grants-2008_05
- Patent number
- US07378409B2
Reaction notes
Loading…